ClinVar Miner

Submissions for variant NM_001203.3(BMPR1B):c.762G>T (p.Arg254Ser)

gnomAD frequency: 0.00001  dbSNP: rs200198618
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Laboratory Services, Illumina RCV000384921 SCV000451661 likely benign Brachydactyly 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease.
Labcorp Genetics (formerly Invitae), Labcorp RCV001861245 SCV002256692 uncertain significance Type A2 brachydactyly; Acromesomelic dysplasia 3 2023-06-20 criteria provided, single submitter clinical testing In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt BMPR1B protein function. ClinVar contains an entry for this variant (Variation ID: 350120). This variant has not been reported in the literature in individuals affected with BMPR1B-related conditions. This variant is present in population databases (rs200198618, gnomAD 0.006%). This sequence change replaces arginine, which is basic and polar, with serine, which is neutral and polar, at codon 254 of the BMPR1B protein (p.Arg254Ser).
Ambry Genetics RCV004021974 SCV004915275 uncertain significance Inborn genetic diseases 2021-06-18 criteria provided, single submitter clinical testing The c.762G>T (p.R254S) alteration is located in exon 9 (coding exon 6) of the BMPR1B gene. This alteration results from a G to T substitution at nucleotide position 762, causing the arginine (R) at amino acid position 254 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.